Tg(CD2-Akt1*)4-1Psoh
Transgene Detail
|
|
| Symbol: |
Tg(CD2-Akt1*)4-1Psoh |
| Name: |
transgene insertion 4-1, Pamela Ohashi |
| MGI ID: |
MGI:5300976 |
| Synonyms: |
hCD2-gag-PKB |
| Transgene: |
Tg(CD2-Akt1*)4-1Psoh Location: unknown
|
| Alliance: |
Tg(CD2-Akt1*)4-1Psoh page
|
|
|
|
| Transgene Type: |
|
Transgenic (Constitutively active, Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: Transgenic mice overexpress a constitutively active form of PKB (gag-PKB (Akt1) in T lymphocytes under control of the human CD2 promoter and locus control region (LCR). The gag-PKB-encoded protein is equivalent to the oncogenic form of PKB, v-akt, and consists of three parts: an in frame fusion of the viral gag protein, a 21-amino acid peptide linker derived primarily from the 5'untranslated region of the endogenous Akt1 gene locus, and Akt1. An NH2-terminal glycine residue of the gag portion of the chimeric protein serves as a site for myristylation. This myristyl group preferentially targets the gag-PKB fusion protein to the cell membrane where it becomes constitutively activated by upstream kinases. Two individual founder lines were established, 5-4 and 4-1.
(J:62176)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:62176 Jones RG, et al., Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med. 2000 May 15;191(10):1721-34 |
| All: |
4 reference(s) |
|